Travaux scientifiques

Prof. Dr. Ahmet Omma

304 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Diagnostic Yield of Internal Medicine Referrals to Rheumatology: A Retrospective Single-Center Study

    Medicina, 2026

    DOI 10.3390/medicina62101943 PMID 42942472 Texte intégral en libre accèsSource : ORCID

  2. Plasma Lipidomic Remodeling in Behçet’s Disease Reveals Alterations Associated with Vascular Involvement

    Metabolites, 2026

    DOI 10.3390/metabo16060363 PMID 42346343 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  3. Can baseline features predict progression to defined connective tissue disease? Insights from a minimum 5-year follow-up study of 504 patients with undifferentiated connective tissue disease: A retrospective study

    Modern rheumatology, 2026

    DOI 10.1093/mr/roag006 PMID 41670330 Source : Europe PMC

  4. Does vascular involvement affect erectile dysfunction in patients with Behçet's disease?: a single-center cross-sectional study

    Sao Paulo medical journal = Revista paulista de medicina, 2026

    DOI 10.1590/1516-3180.2025.3295.12062026 PMID 42788553 Texte intégral en libre accèsSource : Europe PMC

  5. Do different organ involvements cause different comorbidity profiles in Behçet's syndrome?

    Postgraduate medicine, 2026

    DOI 10.1080/00325481.2026.2641859 PMID 41797226 Source : Europe PMC

  6. Non-pulmonary arterial involvement in Behçet's disease: a multicenter retrospective case series

    Turkish journal of medical sciences, 2026

    DOI 10.55730/1300-0144.6206 PMID 42499446 Texte intégral en libre accèsSource : Europe PMC

  7. Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study

    Internal and emergency medicine, 2026

    DOI 10.1007/s11739-026-04349-3 PMID 41946942 Texte intégral en libre accèsSource : Europe PMC

  8. Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study

    Rheumatology, 2026

    DOI 10.1093/rheumatology/keag107 PMID 41734284 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  9. The 2025 Turkish Society for Rheumatology management recommendations for ANCA-associated vasculitides

    Ulusal Romatoloji Dergisi, 2026

    DOI 10.4274/raed.galenos.2025.70883 Texte intégral en libre accèsSource : OpenAlex

  10. Predictors of Cyclophosphamide Resistance in Granulomatosis with Polyangiitis: A Retrospective Cohort Study

    Mediterranean Journal of Rheumatology, 2026

    DOI 10.31138/mjr.150736.pcr PMID 42100069 Texte intégral en libre accèsSource : OpenAlex

  11. Real-world experience of rituximab therapy in ANCA-associated vasculitis according to renal involvement

    Ulusal Romatoloji Dergisi, 2026

    DOI 10.4274/raed.galenos.2026.49368 Texte intégral en libre accèsSource : OpenAlex

  12. Serum calprotectin as a biomarker for large vessel vasculitis: a multicenter cross-sectional study

    International Immunopharmacology, 2026

    DOI 10.1016/j.intimp.2026.117205 PMID 42541830 Source : OpenAlex

  13. The effect of pulmonary nodule presence on disease severity and course in ANCA-associated vasculitis: a multicenter cohort study

    BMC Pulmonary Medicine, 2026

    DOI 10.1186/s12890-026-04625-0 Texte intégral en libre accèsSource : OpenAlex

  14. The role of neopterin in rheumatoid arthritis-related dry eye

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261491820 PMID 42782109 Source : OpenAlex

  15. Adjunctive Acupuncture For Sjögren-Related Dry Eye: A Prospective Sham-Controlled Study

    ESCRS Abstracts, 2026

    DOI 10.82333/nw1x-9d90 Texte intégral en libre accèsSource : OpenAlex

  16. Venous Thromboembolism May Be Increased in the Early Phases of ANCA ‐Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR ‐ VaS Experience

    International Journal of Rheumatic Diseases, 2025

    DOI 10.1111/1756-185x.70506 PMID 41408677 Source : OpenAlex

  17. Turkish Society for Rheumatology guideline for the management of ANCA-associated vasculitides

    Ulusal Romatoloji Dergisi, 2025

    DOI 10.4274/raed.galenos.2025.26349 Texte intégral en libre accèsSource : OpenAlex

  18. Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025

    DOI 10.36141/svdld.v42i3.16880 PMID 41026025 Texte intégral en libre accèsSource : Europe PMC

  19. Novel inflammatory biomarkers for discriminating vascular involvement in Behçet's syndrome: evaluating SII, SIRI, and NPAR

    Biomarkers in medicine, 2025

    DOI 10.1080/17520363.2025.2473312 PMID 40024670 5 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  20. Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

    Wiener klinische Wochenschrift, 2025

    DOI 10.1007/s00508-024-02424-3 PMID 39259223 2 citations (Europe PMC) Source : Europe PMC

  21. Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study

    Seminars in Arthritis and Rheumatism, 2025

    DOI 10.1016/j.semarthrit.2025.152813 PMID 40854262 3 citations (OpenAlex) Source : OpenAlex

  22. Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis

    Journal of Autoimmunity, 2025

    DOI 10.1016/j.jaut.2025.103496 PMID 41207179 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  23. Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

    Reumatismo, 2025

    DOI 10.4081/reumatismo.2025.1792 PMID 40586484 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  24. Long-term outcomes of aortic valve insufficiency in patients with Takayasu arteritis

    Frontiers in Immunology, 2025

    DOI 10.3389/fimmu.2025.1667603 PMID 41058700 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  25. Comorbidity Profile of Familial Mediterranean Fever Patients Varies by Treatments

    Hitit Medical Journal, 2025

    DOI 10.52827/hititmedj.1582847 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  26. The Role of Prognostic Nutritional Index in Vascular Behçet’s Syndrome

    Medical Records, 2025

    DOI 10.37990/medr.1593728 Texte intégral en libre accèsSource : OpenAlex

  27. COVID-19 or systemic lupus erythematosus: Attention to similarity

    Revista română de medicină de laborator, 2025

    DOI 10.2478/rrlm-2025-0002 Texte intégral en libre accèsSource : OpenAlex

  28. Evaluation of digestive symptoms in patients with systemic sclerosis: A cross-sectional study

    Medicine Science | International Medical Journal, 2025

    DOI 10.5455/medscience.2024.12.156 Texte intégral en libre accèsSource : OpenAlex

  29. The role of thiol-disulfide homeostasis in gouty arthropathy

    Ulusal Romatoloji Dergisi, 2025

    DOI 10.4274/raed.galenos.2025.61687 Texte intégral en libre accèsSource : OpenAlex

  30. Serum Semaphorin 3A Levels in Patients with Behçet’s Disease with and without Vascular Involvement

    Bratislavské lekárske listy/Bratislava medical journal, 2025

    DOI 10.1007/s44411-025-00084-x Texte intégral en libre accèsSource : OpenAlex

  31. ABS1137 SCHEDULES AND SURVIVAL OF RITUXIMAB IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS: A MULTI-CENTER, REAL-WORLD EXPERIENCE

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.2087 Texte intégral en libre accèsSource : OpenAlex

  32. ABS0104 Biological treatment may be an option as first steroid-sparing agent in a subgroup of young Takayasu Arteritis patients with prominent acute phase reactants and constitutional symptoms

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.2016 Texte intégral en libre accèsSource : OpenAlex

  33. POS0953 VASCULAR DAMAGE IS LESS PRESENT IN AN EARLY INCEPTION COHORT IN TAKAYASU'S ARTERITIS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.308 Texte intégral en libre accèsSource : OpenAlex

  34. Seasonal variation in incidence and relapse of granulomatosis with polyangiitis: A retrospective cohort study from Central Anatolia.

    Sarcoidosis vasculitis and diffuse lung diseases, 2025

    DOI 10.36141/svdld.v42i2.16537 PMID 40699500 Texte intégral en libre accèsSource : OpenAlex

  35. What are the Anti-Rheumatic Drug Prescribing Patterns in Rheumatoid Arthritis Patients With Chronic Kidney Disease?: A Single-Center Cross-Sectional Study

    Medical Records, 2025

    DOI 10.37990/medr.1729553 Texte intégral en libre accèsSource : OpenAlex

  36. General Characteristics of Rheumatology Consultations in the Emergency Department: Retrospective Results of a Tertiary Hospital

    Archives of Current Medical Research, 2025

    DOI 10.47482/acmr.1659275 Texte intégral en libre accèsSource : OpenAlex

  37. VASCULAR DAMAGE IS LESS PRESENT IN AN EARLY INCEPTION COHORT IN TAKAYASU’S ARTERITIS

    Kocaeli Üniversitesi - AVESİS, 2025

    Source : OpenAlex

  38. Takayasu arteritinde aspirin ve statin kullanımı hastalık prognozunu değiştirebilir mi?

    Kocaeli Üniversitesi - AVESİS, 2025

    Source : OpenAlex

  39. Lupus nefriti klinik ve laboratuvar göstergelerinin incelenmesi: tek merkez deneyimi

    AYBU AVESIS, 2025

    Source : OpenAlex

  40. Biological treatment may be an option as first steroid-sparing agent in a subgroup of young Takayasu Arteritis patients with prominent acute phase reactants and constitutional symptoms

    Kocaeli Üniversitesi - AVESİS, 2025

    Source : OpenAlex

  41. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

    Internal and Emergency Medicine, 2024

    DOI 10.1007/s11739-024-03577-9 PMID 38553624 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  42. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2661 Source : OpenAlex

  43. Role of serum calprotectin in identifying familial Mediterranean fever attacks

    Irish journal of medical science, 2024

    DOI 10.1007/s11845-024-03659-9 PMID 38478181 2 citations (Europe PMC) Source : Europe PMC

  44. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

    Rheumatology international, 2024

    DOI 10.1007/s00296-024-05708-z PMID 39245763 1 citation (Europe PMC) Source : Europe PMC

  45. Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

    Archives of rheumatology, 2024

    DOI 10.46497/archrheumatol.2023.10183 PMID 38774706 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  46. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients

    Turkish journal of medical sciences, 2024

    DOI 10.55730/1300-0144.5768 PMID 38812619 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  47. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis

    Seminars in Arthritis and Rheumatism, 2024

    DOI 10.1016/j.semarthrit.2024.152446 PMID 38669786 15 citations (OpenAlex) Source : OpenAlex

  48. Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study

    Clinical Rheumatology, 2024

    DOI 10.1007/s10067-024-06939-y PMID 38563865 8 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  49. Interstitial Lung Disease in Primary Sjögren's Syndrome: Risk factors for occurrence and radiographic progression.

    Sarcoidosis vasculitis and diffuse lung diseases, 2024

    DOI 10.36141/svdld.v41i3.15548 PMID 39315979 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  50. The burden of face affected questionnaire in patients with systemic sclerosis: Translation, cross-cultural adaptation and psychometric properties in the Turkish version

    The Egyptian Rheumatologist, 2024

    DOI 10.1016/j.ejr.2024.01.002 1 citation (OpenAlex) Source : OpenAlex